Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
24 mai 2024 08h37 HE
|
Stereotaxis, Inc.
Stereotaxis has received CE Mark recertification under the EU’s new Medical Device Regulation (MDR) regulatory framework for all available devices.
Rhino Health and Medinexo Partner to Expand Data Diversity in Therapeutic Development
22 mai 2024 15h35 HE
|
Rhino Health
Rhino Health and Medinexo are partnering to provide federated access to a global network of hospitals to accelerate biopharma research.
Medical Polymer Market worth $60.5 billion by 2029 Globally, at a CAGR of 8.0%, says MarketsandMarkets™
21 mai 2024 04h00 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 21, 2024 (GLOBE NEWSWIRE) -- The Global Medical Polymer Market is projected to grow from USD 41.1 billion in 2024, and it is projected to reach USD 60.5 billion by 2029, at a CAGR of...
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
15 mai 2024 07h32 HE
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Russia Medical Consumables Market Booms to $118.7 Million by 2027: Rising Healthcare Expenditure and Chronic Disease Burden Drive Growth: Ken Research
14 mai 2024 06h19 HE
|
Ken Research
Gurugram, India, May 14, 2024 (GLOBE NEWSWIRE) -- Bandage up for a bonanza! Russia medical consumables market is poised for significant growth, with a projected market size of $118.7 million by...
Kardium visar på utökat kliniskt användningsområde för sin CHS™-coatade Globe-kateter
14 mai 2024 03h54 HE
|
Corline Biomedical AB
Kardium Inc. – en av Corlines kunder, som använder CHS™-ytan på sin Globe-kateter för behandling av hjärtarytmi – meddelar att bolaget med sitt Globe-system framgångsrikt behandlat patienter som lider...
CytoSorbents Reports First Quarter 2024 Results
09 mai 2024 16h17 HE
|
CytoSorbents
CytoSorbents Reports First Quarter 2024 Results
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
09 mai 2024 12h00 HE
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
06 mai 2024 06h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
01 mai 2024 08h31 HE
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...